{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:09:36Z","timestamp":1760954976461},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/s11940-000-0004-3","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T17:43:56Z","timestamp":1180979036000},"page":"215-224","source":"Crossref","is-referenced-by-count":30,"title":["Cerebellar ataxia"],"prefix":"10.1007","volume":"2","author":[{"given":"Susan L.","family":"Perlman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/WNL.51.6.1666","volume":"51","author":"ML Mosely","year":"1998","unstructured":"Mosely ML, Benzow KA, Schut LJ, et al.: Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998, 51:1666\u20131671. This report demonstrates the power of the new molecular genetic diagnostic techniques and lays the groundwork for future gene-based therapies.","journal-title":"Neurology"},{"key":"4_CR2","first-page":"33","volume-title":"Inherited Ataxias","author":"WH Oertel","year":"1993","unstructured":"Oertel WH: Neurotransmitters in the cerebellum. Scientific aspects and clinical relevance. In Inherited Ataxias. Edited by Harding AE, Deufel T. New York: Raven Press; 1993:33\u201375. This is a comprehensive review of the basic science behind the development of drug treatment for ataxia."},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.49.6.1655","volume":"49","author":"ID Wexler","year":"1997","unstructured":"Wexler ID, Hemalatha SG, McConnell J, et al.: Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997, 49:1655\u20131661.","journal-title":"Neurology"},{"key":"4_CR4","first-page":"113","volume-title":"The Inherited Ataxias","author":"D Steinberg","year":"1978","unstructured":"Steinberg D: Elucidation of the metabolic error in Refsum\u2019s disease. Strategy and tactics. In The Inherited Ataxias. Edited by Kark RAP, Rosenberg RN, Schut LJ. New York: Raven Press; 1978:113\u2013124."},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.nu.15.070195.002115","volume":"15","author":"HW Moser","year":"1995","unstructured":"Moser HW, Borel J: Dietary management of X-linked adrenoleukodystrophy. Annu Rev Nutr 1995, 15:379\u2013397.","journal-title":"Annu Rev Nutr"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1212\/WNL.41.3.434","volume":"41","author":"J Peynet","year":"1991","unstructured":"Peynet J, Laurent A, De Liege P, et al.: Cerebrotendinous xanthomatosis. Treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings. Neurology 1991, 41:434\u2013436.","journal-title":"Neurology"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF01799870","volume":"11","author":"AJ MacGilchrist","year":"1988","unstructured":"MacGilchrist AJ, Mills PR, Noble M, et al.: Abetalipoproteinaemia in adults. Role of vitamin therapy. J Inherit Metab Dis 1988, 11:184\u2013190.","journal-title":"J Inherit Metab Dis"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0387-7604(98)00026-6","volume":"20","author":"C Battisti","year":"1998","unstructured":"Battisti C, Toffola ED, Verri AP, et al.: Clinical and stabilometric monitoring in a case of cerebellar atrophy with vitamin E deficiency. Brain Dev 1998, 20:253\u2013257.","journal-title":"Brain Dev"},{"issue":"suppl 1","key":"4_CR9","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1002\/ana.410370711","volume":"37","author":"EJ Dropcho","year":"1995","unstructured":"Dropcho EJ: Autoimmune central nervous system paraneoplastic disorders. Mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995, 37(suppl 1):S102-S113. A thorough review of this important area of cancer management is presented.","journal-title":"Ann Neurol"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.57.1.22","volume":"57","author":"NC Notermans","year":"1994","unstructured":"Notermans NC, van Dijk GW, van der Graaf Y, et al.: Measuring ataxia. Quantification based on the standard neurological examination. J Neurol Neurosurg Psychiatry 1994, 57:22\u201326. This is a useful aid in the assessment of treatment effectiveness.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/02599148709166219","volume":"9","author":"R D\u2019Ambrosio","year":"1987","unstructured":"D\u2019Ambrosio R, Leone M, Rosso MG, et al.: Disability and quality of life in hereditary ataxias. A self-administered postal questionnaire. Int Disabil Stud 1987, 9:10\u201314. This is another useful aid in the assessment of treatment effectiveness.","journal-title":"Int Disabil Stud"},{"key":"4_CR12","first-page":"465","volume":"160","author":"R White","year":"1994","unstructured":"White R, Frank E: Health effects and prevalence of vegetarianism. West J Med 1994, 160:465\u2013471.","journal-title":"West J Med"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.38.9.1478","volume":"38","author":"PL Peterson","year":"1988","unstructured":"Peterson PL, Saad J, Nigro MA: The treatment of Friedreich\u2019s ataxia with amantadine hydrochloride. Neurology 1988, 38:1478\u20131480.","journal-title":"Neurology"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S0317167100047417","volume":"20","author":"A Filla","year":"1993","unstructured":"Filla A, De Michele G, Orefice G, et al.: A double-blind cross-over trial of amantadine hydrochloride in Friedreich\u2019s ataxia. Can J Neurol Sci 1993, 20:52\u201355.","journal-title":"Can J Neurol Sci"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jnnp.61.3.259","volume":"61","author":"MI Botez","year":"1996","unstructured":"Botez MI, Botez-Marquard T, Elie R, et al.: Amantadine hydrochloride treatment in heredodegenerative ataxias. A double blind study. J Neurol Neurosurg Psychiatry 1996, 61:259\u2013264.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archneur.1988.00520350055016","volume":"45","author":"P Trouillas","year":"1988","unstructured":"Trouillas P, Brudon F, Adeleine P: Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol 1988, 45:1217\u20131222.","journal-title":"Arch Neurol"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archneur.1995.00540290042016","volume":"52","author":"P Trouillas","year":"1995","unstructured":"Trouillas P, Serratrice G, Laplane D, et al.: Levorotatory form of 5-hydroxytryptophan in Friedreich\u2019s ataxia. Results of a double-blind drug-placebo cooperative study. Arch Neurol 1995, 52:456\u2013460.","journal-title":"Arch Neurol"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1995.00540290037015","volume":"52","author":"K Wessel","year":"1995","unstructured":"Wessel K, Hermsdorfer J, Deger K, et al.: Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases. Arch Neurol 1995, 52:451\u2013455.","journal-title":"Arch Neurol"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archneur.1995.00540290018003","volume":"52","author":"RD Currier","year":"1995","unstructured":"Currier RD, Collins GM, Subramony SH: Treatment of hereditary ataxia with the levorotatory form of hydroxytryptophan. Arch Neurol 1995, 52:440\u2013441.","journal-title":"Arch Neurol"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/archneur.1997.00550220008002","volume":"54","author":"M Manto","year":"1997","unstructured":"Manto M, Hildebrand J, Godaux E, et al.: Analysis of fast single-joint and multijoint movements in cerebellar cortical atrophy. Failure of L-hydroxytryptophan to improve cerebellar ataxia. Arch Neurol 1997, 54:1192\u20131194.","journal-title":"Arch Neurol"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mds.870120426","volume":"12","author":"JH Friedman","year":"1997","unstructured":"Friedman JH: Machado-Joseph disease\/spinocerebellar ataxia 3 responsive to buspirone. Mov Disord 1997, 12:613\u2013614.","journal-title":"Mov Disord"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archneur.1995.00540340074015","volume":"52","author":"JS Lou","year":"1995","unstructured":"Lou JS, Goldfarb L, McShane L, et al.: Use of buspirone for treatment of cerebellar ataxia. An open-label study. Arch Neurol 1995, 52:982\u2013988.","journal-title":"Arch Neurol"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.1997.00550180059013","volume":"54","author":"P Trouillas","year":"1997","unstructured":"Trouillas P, Xie J, Adeleine P, et al.: Buspirone, a 5-hydroxytryptamine 1A agonist, is active in cerebellar ataxia. Results of a double-blind drug-placebo study in patients with cerebellar cortical atrophy. Arch Neurol 1997, 54:749\u2013752. This is a well-designed study of 19 patients with cerebellar cortical atrophy that establishes buspirone as a useful adjunctive agent for the treatment of ataxia.","journal-title":"Arch Neurol"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/jm981112s","volume":"42","author":"A Cappelli","year":"1999","unstructured":"Cappelli A, Anzini M, Vomero S, et al.: Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors. J Med Chem 1999, 42:1556\u20131575.","journal-title":"J Med Chem"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jnnp.62.3.282","volume":"62","author":"GP Rice","year":"1997","unstructured":"Rice GP, Lesaux J, Vandervoort P, et al.: Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor. J Neurol Neurosurg Psychiatry 1997, 62:282\u2013284.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.31.3.288","volume":"31","author":"RAP Kark","year":"1981","unstructured":"Kark RAP, Budelli MMR, Wachsner R: Double-blind, triple-crossover trial of low doses of oral physostigmine in inherited ataxias. Neurology 1981, 31:288\u2013292.","journal-title":"Neurology"},{"key":"4_CR27","first-page":"311","volume":"67","author":"JC Aschoff","year":"1996","unstructured":"Aschoff JC, Kailer NA, Walter K: Physostigmine in treatment of cerebellar ataxia. Nervenarzt 1996, 67:311\u2013318.","journal-title":"Nervenarzt"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.1990.00530110048016","volume":"47","author":"BV Manyam","year":"1990","unstructured":"Manyam BV, Giacobini E, Ferraro TN, et al.: Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia. Arch Neurol 1990, 47:1194\u20131199.","journal-title":"Arch Neurol"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.1997.00550160041013","volume":"54","author":"K Wessel","year":"1997","unstructured":"Wessel K, Langenberger K, Nitschke MF, et al.: Doubleblind crossover study with physostigmine in patients with degenerative cerebellar diseases. Arch Neurol 1997, 54:397\u2013400.","journal-title":"Arch Neurol"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11940-999-0027-3","volume":"1","author":"D Lambert","year":"1999","unstructured":"Lambert D, Waters CH: Essential tremor. Curr Treat Options Neurol 1999, 1:6\u201313. This is a superb review of kinetic tremor as it applies to cerebellar disease.","journal-title":"Curr Treat Options Neurol"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00002826-198812000-00005","volume":"11","author":"U Bonuccelli","year":"1988","unstructured":"Bonuccelli U, Nuti A, Cei G, et al.: Oral thyrotropinreleasing hormone treatment in inherited ataxias. Clin Neuropharmacol 1988, 11:520\u2013528.","journal-title":"Clin Neuropharmacol"},{"key":"4_CR32","first-page":"83","volume":"59","author":"A Filla","year":"1989","unstructured":"Filla A, De Michele G, Di Martino L, et al.: Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects [in Italian]. Riv Neurol 1989, 59:83\u201388.","journal-title":"Riv Neurol"},{"key":"4_CR33","first-page":"587","volume":"37","author":"M Waragai","year":"1997","unstructured":"Waragai M, Ogawara K, Takaya Y, et al.: Efficacy of TRH-T for spinocerebellar degeneration. The relation between clinical features and effect of TRH therapy [in Japanese]. Rinsho Shinkeigaku 1997, 37:587\u2013594.","journal-title":"Rinsho Shinkeigaku"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00002826-198612000-00002","volume":"9","author":"BV Manyam","year":"1986","unstructured":"Manyam BV: Recent advances in the treatment of cerebellar ataxia. Clin Neuropharmacol 1986, 9:508\u2013516.","journal-title":"Clin Neuropharmacol"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/106002809002400906","volume":"24","author":"EA Blumberg","year":"1990","unstructured":"Blumberg EA, Gil RA: Cerebellar syndrome caused by isoniazid. DICP 1990, 24:829\u2013831.","journal-title":"DICP"},{"key":"4_CR36","first-page":"292","volume":"43","author":"YD Shu","year":"1989","unstructured":"Shu YD, Chang MK, Hsein HH: Isoniazid therapy in severe cerebellar, postural, and kinetic tremor [in Chinese]. Chung Hua I Hsueh Tsa Chih 1989, 43:292\u2013298.","journal-title":"Chung Hua I Hsueh Tsa Chih"},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.39.8.1113","volume":"39","author":"GP Sechi","year":"1989","unstructured":"Sechi GP, Zuddas M, Piredda M, et al.: Treatment of cerebellar tremors with carbamazepine. A controlled trial with long-term follow-up. Neurology 1989, 39:1113\u20131115.","journal-title":"Neurology"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11940-999-0034-4","volume":"1","author":"L Averbuch-Heller","year":"1999","unstructured":"Averbuch-Heller L: Acquired nystagmus. Curr Treat Options Neurol 1999, 1:68\u201373. This is a superb review of nystagmus as it applies to cerebellar disease.","journal-title":"Curr Treat Options Neurol"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp.65.4.565","volume":"65","author":"JC Jen","year":"1998","unstructured":"Jen JC, Yue Q, Karrim J, et al.: Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 1998, 65:565\u2013568. The area of overlapping phenotypes in the ataxic ion channelopathies is clarified.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jnnp.59.4.400","volume":"59","author":"WJ Lubbers","year":"1995","unstructured":"Lubbers WJ, Brunt ER, Scheffer H, et al.: Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide. J Neurol Neurosurg Psychiatry 1995, 59:400\u2013405.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-510X(96)00244-4","volume":"145","author":"SM Baig","year":"1997","unstructured":"Baig SM: Acetazolamide therapy improves action myoclonus in Ramsay Hunt syndrome. J Neurol Sci 1997, 145:123\u2013124.","journal-title":"J Neurol Sci"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1749-6632.1988.tb33414.x","volume":"522","author":"J Olesen","year":"1988","unstructured":"Olesen J: Calcium entry blockers in the treatment of vertigo. Ann N Y Acad Sci 1988, 522:690\u2013697.","journal-title":"Ann N Y Acad Sci"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-2008-1052450","volume":"19","author":"M Boel","year":"1988","unstructured":"Boel M, Casaer P: Familial periodic ataxia responsive to flunarizine. Neuropediatrics 1988, 19:218\u2013220.","journal-title":"Neuropediatrics"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1212\/WNL.39.10.1400","volume":"39","author":"GM Seliger","year":"1989","unstructured":"Seliger GM, Hornstein A: Serotonin, fluoxetine, and pseudobulbar affect. Neurology 1989, 39:1400. The first really effective drug option for brain stem-mediated dysarthria and dysphagia is presented.","journal-title":"Neurology"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0022-510X(96)00153-0","volume":"139","author":"J Finsterer","year":"1996","unstructured":"Finsterer J, Muellbacher W, Mamoli B: Yes\/yes head tremor without appendicular tremor after bilateral cerebellar infarction. J Neurol Sci 1996, 139:242\u2013245.","journal-title":"J Neurol Sci"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1996.00550070055012","volume":"53","author":"SL Pullman","year":"1996","unstructured":"Pullman SL, Greene P, Fahn S, et al.: Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Arch Neurol 1996, 53:617\u2013624.","journal-title":"Arch Neurol"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00019052-199612000-00009","volume":"6","author":"JP Nguyen","year":"1996","unstructured":"Nguyen JP, Feve A, Keravel Y: Is electrostimulation preferable to surgery for upper limb ataxia? Curr Opin Neurol 1996, 6:445\u2013450.","journal-title":"Curr Opin Neurol"},{"key":"4_CR48","first-page":"245","volume":"65","author":"SJ Koch","year":"1986","unstructured":"Koch SJ, Arego DE, Bowser B: Outpatient rehabilitation for chronic neuromuscular diseases. Am J Phys Med 1986, 65:245\u2013257.","journal-title":"Am J Phys Med"},{"key":"4_CR49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mus.880090310","volume":"9","author":"SL Perlman","year":"1986","unstructured":"Perlman SL, Kern RI: Intensive physical therapy for chronic progressive neuromuscular disease [abstract]. Musc Nerv 1986, 9:257. A prospective nonrandomized study of 20 patients with a variety of cerebellar syndromes is discussed, demonstrating qualitative and quantitative gains in function.","journal-title":"Musc Nerv"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ptj\/77.6.672","volume":"77","author":"AJ Bastian","year":"1997","unstructured":"Bastian AJ: Mechanisms of ataxia. Phys Ther 1997, 77:672\u2013675.","journal-title":"Phys Ther"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2007-1000747","volume":"57","author":"U Jobst","year":"1989","unstructured":"Jobst U: Posturographic biofeedback training in equilibrium disorders [in German]. Fortschr Neurol Psychiatr 1989, 57:74\u201380.","journal-title":"Fortschr Neurol Psychiatr"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1212\/WNL.51.3.838","volume":"51","author":"M Strupp","year":"1998","unstructured":"Strupp M, Arbusow V, Maag KP, et al.: Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis. Neurology 1998, 51:838\u2013844.","journal-title":"Neurology"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/archneur.55.11.1394","volume":"55","author":"RN Rosenberg","year":"1998","unstructured":"Rosenberg RN: Alternative neurology. Arch Neurol 1998, 55:1394\u20131395.","journal-title":"Arch Neurol"},{"key":"4_CR54","volume-title":"Reader\u2019s Guide to Alternative Health Methods","author":"JF Zwicky","year":"1993","unstructured":"Zwicky JF, Hafner AW, Barrett S, et al. Reader\u2019s Guide to Alternative Health Methods. Washington, DC: American Medical Association; 1993. This is a critical analysis of more than 1000 reports on unproven, disproven, controversial, fraudulent, quack, or otherwise questionable approaches to solving health problems. The baby may be thrown out with the bath water, however; the book does not recognize the renewed hope that these patient-empowering approaches may engender."},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H","volume":"46","author":"D Waldvogel","year":"1999","unstructured":"Waldvogel D, van Gelderen P, Hallett M: Increased iron in the dentate nucleus of patients with Friedreich\u2019s ataxia. Ann Neurol 1999, 46:123\u2013125.","journal-title":"Ann Neurol"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0005-2728(98)00115-7","volume":"1366","author":"AH Schapira","year":"1998","unstructured":"Schapira AH: Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta 1998, 1366:225\u2013233. A clear and thorough review of current thinking regarding the pathogenesis of neurodegeneration and possible treatment strategies is presented.","journal-title":"Biochim Biophys Acta"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.47.5.1264","volume":"47","author":"RW Hurd","year":"1996","unstructured":"Hurd RW, Wilder BJ, Helveston WR, et al.: Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Neurology 1996, 47:1264\u20131268.","journal-title":"Neurology"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1073\/pnas.95.3.1253","volume":"95","author":"AM Fernandez","year":"1998","unstructured":"Fernandez AM, de la Vega AG, Torres-Aleman I: Insulinlike growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc Natl Acad Sci U S A 1998, 95:1253\u20131258.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR59","first-page":"198","volume":"104","author":"W Cheng-yuan","year":"1991","unstructured":"Cheng-yuan W, Xiu-feng B, Cheng Z, et al.: Fetal tissue grafts for cerebellar atrophy. Chin Med J 1991, 104:198\u2013203.","journal-title":"Chin Med J"},{"key":"4_CR60","unstructured":"National Ataxia Foundation Web site: http:\/\/ www.ataxia.org. This is a well-developed, informative resource for clinician and patient alike, highlighting advances in diagnosis and treatment of ataxic disorders."}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-000-0004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-000-0004-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-000-0004-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:42Z","timestamp":1559437002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-000-0004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11940-000-0004-3","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}